贝伐单抗联合吉非替尼一线治疗晚期 EGFR 突变的肺腺癌的临床观察

Clinical observation of bevacizumab combined with gefitinib in first-line treatment of advanced lung adenocarcinoma with EGFR mutation

Authors: ¹DONG Lei
¹ Oncology Department, Haigang Hospital, Qinhuangdao Hebei 066000, China